MX2019000037A - Metodos para perfilado de fragmentoma de acidos nucleicos libres de celula. - Google Patents

Metodos para perfilado de fragmentoma de acidos nucleicos libres de celula.

Info

Publication number
MX2019000037A
MX2019000037A MX2019000037A MX2019000037A MX2019000037A MX 2019000037 A MX2019000037 A MX 2019000037A MX 2019000037 A MX2019000037 A MX 2019000037A MX 2019000037 A MX2019000037 A MX 2019000037A MX 2019000037 A MX2019000037 A MX 2019000037A
Authority
MX
Mexico
Prior art keywords
cell
methods
dna
nucleic acids
free nucleic
Prior art date
Application number
MX2019000037A
Other languages
English (en)
Spanish (es)
Inventor
Abdueva Diana
Original Assignee
Guardant Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guardant Health Inc filed Critical Guardant Health Inc
Publication of MX2019000037A publication Critical patent/MX2019000037A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2019000037A 2016-07-06 2017-07-06 Metodos para perfilado de fragmentoma de acidos nucleicos libres de celula. MX2019000037A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662359151P 2016-07-06 2016-07-06
US201662420167P 2016-11-10 2016-11-10
US201662437172P 2016-12-21 2016-12-21
US201762489399P 2017-04-24 2017-04-24
PCT/US2017/040986 WO2018009723A1 (en) 2016-07-06 2017-07-06 Methods for fragmentome profiling of cell-free nucleic acids

Publications (1)

Publication Number Publication Date
MX2019000037A true MX2019000037A (es) 2019-07-10

Family

ID=60913158

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000037A MX2019000037A (es) 2016-07-06 2017-07-06 Metodos para perfilado de fragmentoma de acidos nucleicos libres de celula.

Country Status (11)

Country Link
EP (2) EP3481966B1 (enExample)
JP (3) JP7448310B2 (enExample)
KR (1) KR102610098B1 (enExample)
CN (1) CN109689891B (enExample)
AU (1) AU2017292854B2 (enExample)
BR (1) BR112019000296A2 (enExample)
CA (1) CA3030038A1 (enExample)
ES (1) ES2967443T3 (enExample)
MX (1) MX2019000037A (enExample)
SG (1) SG11201811556RA (enExample)
WO (1) WO2018009723A1 (enExample)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
EP2656263B1 (en) 2010-12-22 2019-11-06 Natera, Inc. Methods for non-invasive prenatal paternity testing
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
AU2012242847B2 (en) 2011-04-15 2017-01-19 The Johns Hopkins University Safe sequencing system
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
ES2701742T3 (es) 2012-10-29 2019-02-25 Univ Johns Hopkins Prueba de Papanicolaou para cánceres de ovario y de endometrio
CN113774132A (zh) 2014-04-21 2021-12-10 纳特拉公司 检测染色体片段中的突变和倍性
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
US10453556B2 (en) 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
WO2017027653A1 (en) 2015-08-11 2017-02-16 The Johns Hopkins University Assaying ovarian cyst fluid
EP3433382B1 (en) 2016-03-25 2021-09-01 Karius, Inc. Synthetic nucleic acid spike-ins
DK3443119T3 (da) 2016-04-15 2022-05-23 Natera Inc Fremgangsmåde til bestemmelse af lunge cancer
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
WO2018119452A2 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
ES2990117T3 (es) 2017-01-25 2024-11-28 Univ Hong Kong Chinese Aplicaciones de diagnóstico que utilizan fragmentos de ácido nucleico
WO2019016353A1 (en) * 2017-07-21 2019-01-24 F. Hoffmann-La Roche Ag CLASSIFICATION OF SOMATIC MUTATIONS FROM A HETEROGENEOUS SAMPLE
CN120400338A (zh) 2017-08-07 2025-08-01 约翰斯霍普金斯大学 用于评估和治疗癌症的方法和材料
WO2019060716A1 (en) 2017-09-25 2019-03-28 Freenome Holdings, Inc. SAMPLE EXTRACTION METHODS AND SYSTEMS
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3743518A4 (en) * 2018-01-24 2021-09-29 Freenome Holdings, Inc. METHODS AND SYSTEMS FOR DETECTING ANOMALY IN PATTERNS OF NUCLEIC ACIDS
IL321982A (en) * 2018-02-27 2025-09-01 Univ Cornell Systems and methods for detecting residual disease
JP2021519607A (ja) 2018-02-27 2021-08-12 コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ ゲノムワイド統合による循環腫瘍ｄｎａの超音波感受性検出
WO2019173552A1 (en) 2018-03-08 2019-09-12 St. John's University Circulating serum cell-free dna biomarkers and methods
WO2019178289A1 (en) 2018-03-13 2019-09-19 Grail, Inc. Method and system for selecting, managing, and analyzing data of high dimensionality
WO2019178563A1 (en) * 2018-03-15 2019-09-19 The Board Of Trustees Of Leland Stanford Junior University Methods using nucleic acid signals for revealing biological attributes
WO2019200404A2 (en) * 2018-04-13 2019-10-17 Grail, Inc. Multi-assay prediction model for cancer detection
CA3095056A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
DK3781714T3 (da) 2018-04-14 2026-03-30 Natera Inc Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
CN112888459B (zh) 2018-06-01 2023-05-23 格里尔公司 卷积神经网络系统及数据分类方法
WO2020006369A1 (en) * 2018-06-29 2020-01-02 Guardant Health, Inc. Methods and systems for analysis of ctcf binding regions in cell-free dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
JP7637615B2 (ja) * 2018-09-04 2025-02-28 ガーダント ヘルス， インコーポレイテッド 無細胞核酸試料におけるアレル不均衡を検出するための方法およびシステム
EP3815005A4 (en) * 2018-10-08 2022-03-30 Freenome Holdings, Inc. Transcription factor profiling
GB201818159D0 (en) * 2018-11-07 2018-12-19 Cancer Research Tech Ltd Enhanced detection of target dna by fragment size analysis
EP4428234B1 (en) 2018-11-21 2025-12-24 Karius, Inc. Direct-to-library methods, systems, and compositions
WO2020106987A1 (en) * 2018-11-21 2020-05-28 Karius, Inc. Detection and prediction of infectious disease
US10468141B1 (en) * 2018-11-28 2019-11-05 Asia Genomics Pte. Ltd. Ancestry-specific genetic risk scores
US11581062B2 (en) 2018-12-10 2023-02-14 Grail, Llc Systems and methods for classifying patients with respect to multiple cancer classes
TW202536188A (zh) * 2018-12-19 2025-09-16 香港中文大學 游離dna末端特徵
WO2020127629A1 (en) * 2018-12-21 2020-06-25 F. Hoffmann-La Roche Ag Identification of global sequence features in whole genome sequence data from circulating nucelic acid
WO2020132499A2 (en) * 2018-12-21 2020-06-25 Grail, Inc. Systems and methods for using fragment lengths as a predictor of cancer
WO2020150258A1 (en) * 2019-01-15 2020-07-23 Luminist, Inc. Methods and systems for detecting liver disease
KR102916051B1 (ko) * 2019-01-24 2026-01-21 일루미나, 인코포레이티드 장기 건강 및 질환을 모니터링하기 위한 방법 및 시스템
CA3126428A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
CA3130203A1 (en) 2019-02-12 2020-08-20 Tempus Labs, Inc. Detection of human leukocyte antigen loss of heterozygosity
US11475978B2 (en) 2019-02-12 2022-10-18 Tempus Labs, Inc. Detection of human leukocyte antigen loss of heterozygosity
WO2020176659A1 (en) * 2019-02-27 2020-09-03 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free dna
US20220154249A1 (en) * 2019-04-15 2022-05-19 Natera, Inc. Improved liquid biopsy using size selection
US12497662B2 (en) 2019-04-16 2025-12-16 Grail, Inc. Systems and methods for tumor fraction estimation from small variants
US11869661B2 (en) 2019-05-22 2024-01-09 Grail, Llc Systems and methods for determining whether a subject has a cancer condition using transfer learning
US11939636B2 (en) 2019-05-31 2024-03-26 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
EP3980559A1 (en) 2019-06-06 2022-04-13 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
EP3997242B1 (en) * 2019-07-09 2026-04-08 The Translational Genomics Research Institute Methods of detecting disease and treatment response in cfdna
US20220301654A1 (en) * 2019-08-28 2022-09-22 Grail, Llc Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids
CN110706749B (zh) * 2019-09-10 2022-06-10 至本医疗科技（上海）有限公司 一种基于组织器官分化层次关系的癌症类型预测系统和方法
CA3151538A1 (en) 2019-09-30 2021-04-08 Stefanie Ann Ward Mortimer Compositions and methods for analyzing cell-free dna in methylation partitioning assays
EP4715839A2 (en) 2019-10-11 2026-03-25 Guardant Health, Inc. Use of cell free bacterial nucleic acids for detection of cancer
CN114746560A (zh) 2019-11-26 2022-07-12 夸登特健康公司 改进甲基化多核苷酸结合的方法、组合物和系统
KR102586651B1 (ko) * 2019-11-29 2023-10-11 주식회사 지씨지놈 인공지능 기반 염색체 이상 검출 방법
CN115151657A (zh) * 2019-12-20 2022-10-04 安可济控股有限公司 用于疾病检测的方法和系统
WO2021130356A1 (en) * 2019-12-24 2021-07-01 Vib Vzw Disease detection in liquid biopsies
IL295297A (en) 2020-02-14 2022-10-01 Univ Johns Hopkins Methods and materials for assessing nucleic acids
AU2021227920A1 (en) * 2020-02-28 2022-09-08 Grail, Llc Systems and methods for calling variants using methylation sequencing data
CA3177127A1 (en) 2020-04-30 2021-11-04 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
IL298458A (en) * 2020-05-22 2023-01-01 Aqtual Inc Methods for characterizing cell-free nucleic acid fragments
EP4179111B1 (en) 2020-07-10 2024-04-03 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
WO2022026761A1 (en) 2020-07-30 2022-02-03 Guardant Health, Inc. Methods for isolating cell-free dna
CN116157868A (zh) * 2020-08-18 2023-05-23 德尔菲诊断公司 用于游离dna片段大小密度以评估癌症的方法和系统
WO2022046947A1 (en) 2020-08-25 2022-03-03 Guardant Health, Inc. Methods and systems for predicting an origin of a variant
EP4214329A4 (en) * 2020-09-17 2024-12-04 The Regents of the University of Colorado, a body corporate Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
WO2022073012A1 (en) 2020-09-30 2022-04-07 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease
WO2022087309A1 (en) 2020-10-23 2022-04-28 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and base conversion
CA3199829A1 (en) 2020-11-30 2022-06-02 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
CN114634982A (zh) * 2020-12-15 2022-06-17 广州市基准医疗有限责任公司 一种检测多核苷酸变异的方法
EP4015650A1 (en) * 2020-12-18 2022-06-22 Nipd Genetics Biotech Limited Methods for classifying a sample into clinically relevant categories
WO2022140629A1 (en) 2020-12-23 2022-06-30 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
EP4729633A2 (en) 2021-02-12 2026-04-22 Guardant Health, Inc. Methods for detecting nucleic acid variants
EP4314329A1 (en) 2021-03-25 2024-02-07 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
EP4320277A4 (en) * 2021-04-08 2025-03-05 Delfi Diagnostics, Inc. CANCER DETECTION METHOD USING GENOME-WIDE CELL-FREE DNA FRAGMENTATION PROFILES
WO2022248844A1 (en) * 2021-05-24 2022-12-01 University Of Essex Enterprises Limited Method and system for identifying genomic regions with condition sensitive occupancy/positioning of nucleosomes and/or chromatin
KR102927037B1 (ko) * 2021-05-28 2026-02-13 주식회사 지씨지놈 조직 특이적 조절 지역의 무세포 dna 분포를 이용한 인공지능 기반 암 조기진단 방법
CN113838533B (zh) * 2021-08-17 2024-03-12 福建和瑞基因科技有限公司 一种癌症检测模型及其构建方法和试剂盒
EP4433611A4 (en) * 2021-11-17 2025-10-08 Univ Leland Stanford Junior SYSTEMS AND METHODS FOR GENE EXPRESSION AND TISSUE OF ORIGIN INFERENCE FROM CIRCULATING FREE DNA
KR102884871B1 (ko) * 2022-01-26 2025-11-11 권창혁 암 판별 장치 및 암 판별 방법
CA3245713A1 (en) * 2022-03-17 2023-09-21 Delfi Diagnostics, Inc. CANCER SURVEILLANCE METHOD USING FRAGMENTATION PROFILES
EP4504971A1 (en) 2022-04-07 2025-02-12 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
EP4532762A1 (en) * 2022-06-02 2025-04-09 The Board Of Trustees Of The Leland Stanford Junior University Single molecule sequencing and methylation profiling of cell-free dna
EP4547857A1 (en) 2022-06-30 2025-05-07 Guardant Health, Inc. Enrichment of aberrantly methylated dna
US20240043935A1 (en) * 2022-07-29 2024-02-08 Centre For Novostics Limited Epigenetics analysis of cell-free dna
WO2024073508A2 (en) 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
CN115295074B (zh) * 2022-10-08 2022-12-16 南京世和基因生物技术股份有限公司 基因标志物在恶性肺结节筛查中的应用、筛查模型的构建方法和检测装置
WO2024112643A1 (en) * 2022-11-21 2024-05-30 Foundation Medicine, Inc. Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy
WO2024138180A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Integrated targeted and whole genome somatic and dna methylation sequencing workflows
EP4638781A2 (en) 2022-12-22 2025-10-29 Guardant Health, Inc. Methods involving methylation preserving amplification with error correction
EP4705522A1 (en) 2023-05-05 2026-03-11 Guardant Health, Inc. Cell-free dna blood-based test for cancer screening
CN116665784B (zh) * 2023-05-31 2025-12-30 华中农业大学 基于cfDNA全基因组测序数据识别染色质开放区域的方法、癌症预测模型及系统
WO2025019370A1 (en) * 2023-07-14 2025-01-23 Natera, Inc. Methods for assaying circulating tumor dna
WO2025029475A1 (en) 2023-07-28 2025-02-06 Guardant Health, Inc. Methods to enrich nucleotide variants by negative selection
WO2025038399A1 (en) 2023-08-11 2025-02-20 Guardant Health, Inc. Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
CN117230165A (zh) * 2023-09-01 2023-12-15 深圳湾实验室 一种无创产前检测胎儿染色体拷贝数异常的优化方法
WO2025064706A1 (en) 2023-09-19 2025-03-27 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
WO2025076452A1 (en) 2023-10-06 2025-04-10 Guardant Health, Inc. Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
WO2025207817A1 (en) 2024-03-26 2025-10-02 Guardant Health, Inc. Method of determining the likelihood of a disease by combining biomarkers and imaging
WO2025208044A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for cancer detection using molecular patterns
WO2025205006A1 (ja) * 2024-03-29 2025-10-02 ソニーグループ株式会社 分析方法、クロマチン状態を分類する方法、がん検査方法、分析システム、がん又は微小残存病変の検査システムおよび分析キット
WO2025235889A1 (en) 2024-05-10 2025-11-13 Guardant Health, Inc. Methods involving multiplexed pooled pcr
WO2025250544A1 (en) 2024-05-31 2025-12-04 Guardant Health, Inc. Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
WO2026043718A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods to monitor patients treated with a cancer vaccine
WO2026073140A1 (en) 2024-09-27 2026-04-02 Guardant Health, Inc. Framework to identify genomic regions indicative of one or more biological conditions
WO2026076332A1 (en) 2024-10-03 2026-04-09 Guardant Health, Inc. Methods involving multi-modal tumor variant identification and tracking of tumor molecules
WO2026090570A1 (en) 2024-10-24 2026-04-30 Guardant Health, Inc. Detecting the presence of a biological condition based on a nucleic acid sample data analysis
CN119905148B (zh) * 2024-12-30 2026-02-06 西藏自治区农牧科学院水产科学研究所 一种核间等位基因表达分析方法、装置及存储介质
CN120334449B (zh) * 2025-06-20 2025-09-05 陕西右任故里茯砖茶股份有限公司 基于液相色谱的茯砖茶中金花菌发酵检测方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0920069A8 (pt) 2008-10-30 2017-10-03 Centre De Rech Public De La Sante Biomarcadores
CN101901345B (zh) * 2009-05-27 2013-02-27 复旦大学 一种差异蛋白质组学的分类方法
US11322224B2 (en) * 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2426217A1 (en) * 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
CA2840418C (en) * 2011-07-26 2019-10-29 Verinata Health, Inc. Method for determining the presence or absence of different aneuploidies in a sample
US9367663B2 (en) * 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3922731A3 (en) 2011-10-06 2022-01-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2866587C (en) 2012-02-16 2022-07-26 Oxford Nanopore Technologies Limited Analysis of measurements of a polymer
AU2013232123B2 (en) * 2012-03-13 2014-10-30 The Chinese University Of Hong Kong Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis
CN108485940B (zh) * 2012-04-12 2022-01-28 维里纳塔健康公司 拷贝数变异的检测和分类
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
DE202013012824U1 (de) * 2012-09-04 2020-03-10 Guardant Health, Inc. Systeme zum Erfassen von seltenen Mutationen und einer Kopienzahlvariation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20130309666A1 (en) * 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN114574581A (zh) * 2013-03-15 2022-06-03 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
EP3011052B1 (en) * 2013-06-17 2019-05-22 Verinata Health, Inc Method for determining copy number variations in sex chromosomes
US9499870B2 (en) * 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
ES2660989T3 (es) 2013-12-28 2018-03-27 Guardant Health, Inc. Métodos y sistemas para detectar variantes genéticas
JP6659672B2 (ja) * 2014-05-30 2020-03-04 ベリナタ ヘルス インコーポレイテッド 胎児染色体部分異数性およびコピー数変動の検出
CA2956208C (en) * 2014-07-25 2025-07-08 University Of Washington METHODS FOR DETERMINING TISSUES AND/OR CELL TYPES RENDERING CELL-FREE DNA AND RELATED METHODS FOR DETERMINING A DISEASE OR DISORDER
AU2015360298B2 (en) * 2014-12-12 2018-06-07 Verinata Health, Inc. Using cell-free DNA fragment size to determine copy number variations

Also Published As

Publication number Publication date
SG11201811556RA (en) 2019-01-30
EP3481966B1 (en) 2023-11-08
KR20190026837A (ko) 2019-03-13
JP2024119898A (ja) 2024-09-03
CN109689891B (zh) 2024-06-18
KR102610098B1 (ko) 2023-12-04
WO2018009723A1 (en) 2018-01-11
EP3481966A4 (en) 2019-08-07
EP4322168A3 (en) 2024-05-15
JP2019531700A (ja) 2019-11-07
AU2017292854B2 (en) 2023-08-17
CA3030038A1 (en) 2018-01-11
EP3481966A1 (en) 2019-05-15
ES2967443T3 (es) 2024-04-30
JP7448310B2 (ja) 2024-03-12
CN109689891A (zh) 2019-04-26
AU2017292854A1 (en) 2019-01-24
EP4322168A2 (en) 2024-02-14
JP2022025101A (ja) 2022-02-09
BR112019000296A2 (pt) 2019-04-16

Similar Documents

Publication Publication Date Title
EP4322168A3 (en) Methods for fragmentome profiling of cell-free nucleic acids
EP4527942A3 (en) Preserving genomic connectivity information in fragmented genomic dna samples
FI3604532T3 (fi) Uusia crispr-entsyymejä ja järjestelmiä
MX2016016713A (es) Procesos y sistemas para el montaje de secuencias de acido nucleico.
AU2017257225A1 (en) Allele editing and applications thereof
HK1258869A1 (zh) 寡核酸变体文库及其合成
BR112015012375A2 (pt) modificação e regulação de genoma à base de crispr
MX2017008670A (es) Moleculas artificiales de acido nucleico novedosas.
GB201808146D0 (en) Stereospecific Linkages in RNA Editing Oligonucleotides
SG10201805815YA (en) Rna-guided gene drives
SG10201809566SA (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
BR112015031639A2 (pt) integração alvo
SA518391294B1 (ar) التحرير المتعدد للجينوم
EP4667583A3 (en) Multiple tagging of long dna fragments
EP4410978A3 (en) Methods for quantitative genetic analysis of cell free dna
CA2983023A1 (en) Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
MX2022009242A (es) Producto en desarrollo de analisis de secuenciacion de alineacion y variante.
EP3699280A3 (en) Novel cas9 systems and methods of use
NZ728437A (en) Methods for increasing cas9-mediated engineering efficiency
HK1246180A1 (zh) 使用自然杀伤细胞治疗血液病症、实体瘤或感染性疾病的方法
WO2014116729A3 (en) Haplotying of hla loci with ultra-deep shotgun sequencing
GEP20217251B (en) Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
GB2511690A (en) Detecting malware using stored patterns
MY200537A (en) Methods and compositions for dna profiling
EP4604127A3 (en) Methods and processes for non-invasive assessment of genetic variations